Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "IDA"

1783 News Found

Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr
News | November 06, 2023

Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr

Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023


Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr
News | November 06, 2023

Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr

Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023


Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr
News | November 04, 2023

Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023


Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
News | November 03, 2023

Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr

Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023


Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr
News | November 03, 2023

Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr

The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023


Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr
News | November 03, 2023

Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr

Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023


Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr
News | November 03, 2023

Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023


Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
News | November 02, 2023

Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr

The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202


Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr
News | November 02, 2023

Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr

Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023


Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr
News | November 01, 2023

Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr

Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023